Breast cancer solution

- Facilitates the collaboration of your multidisciplinary team.
- Helps ensure appropriate breast cancer patient care and satisfaction.
- Helps to optimize clinical performance with advanced and technologically innovative products for each step of the patient care pathway.

breast cancer

Screening

GE Breast Tomosynthesis (Digital Breast Tomosynthesis)
A 3D imaging technology that uses a low dose short X-ray sweep around a compressed breast. This imaging technique is designed to separate the tissues and to reduce the overlapping of structures to help increase breast cancer detection.


Senographe* Care (Digital Mammography) Introducing the Senographe Care digital mammography system. With GE Healthcare’s Senographe digital mammography products, you can do it all. Screening. Diagnosis. Interventional. GE Healthcare’s digital solutions offer outstanding reliability, smooth workflow and a stable detector. With Senographe Care, you can choose only the technology you need.


Senographe Essential (Digital Mammography) The Senographe Essential full-field digital system is designed to give you what you need to perform high-quality mammograms. It is GE’s flagship mammography product that lets you perform a wide variety of breast procedures—from in-office screening, diagnostics, interventions and mobile screenings.

SenoBright* (contrast enhanced spectral mammography)
SenoBright, based on a new GE Contrast Enhanced Spectral Mammography (CESM**) technology, is a combination of digital mammography with an intravenous injection of iodine, a common contrast agent. The exam provides two images per view of both breasts, one which shows tissue morphology like a standard mammography image, the second revealing an iodine-contrasted image that may assists radiologists in localizing a known or suspected lesion.


*Trademark(s) of General Electric company

Diagnosis

Molecular Breast Imaging
The Discovery* NM750b Molecular Breast maging system from GE Healthcare was designed to help enable you to make critical contributions to breast-cancer care, from diagnosis and planning through treatment monitoring. It provides consistently high sensitivity, even in patients with dense breasts, in a highly efficient and affordable device.

MRI with DCE
For women with dense breast tissue or those at high-risk for breast cancer due to family history, MRI is often recommended to provide additional imaging to improve diagnosis. The use of MRI can help physicians to better analyse abnormalities detected through mammography. The ability to see more clearly with the VIBRANT applications can aid in a quick diagnosis and decisionmaking to prevent unnecessary mastectomies and/or to monitor therapy.

Ultrasound
Dedicated ultrasound solutions are important for detecting and defining masses in breast tissue in order to perform guided biopsies. GE offers a comprehensive range of 3D ultrasound technologies, including portable solutions for small clinics and mobile units.


Senographe* Care (Digital Mammography) Introducing the Senographe Care digital mammography system. With GE Healthcare’s Senographe digital mammography products, you can do it all. Screening. Diagnosis. Interventional. GE Healthcare’s digital solutions offer outstanding reliability, smooth workflow and a stable detector. With Senographe Care, you can choose only the technology you need.

OncoQuant*
A true cross-modality oncology reading platform, OncoQuant helps you correlate and compare CT, MR, PET /CT, and 3D X-ray data. It automates workflow from your PACS , facilitating easy comparisons over time and efficient follow-up exams.

Molecular diagnostics 


*Trademark(s) of General Electric company

Biopsy

MRI with DCE
For women with dense breast tissue or those at high-risk for breast cancer due to family history, MRI is often recommended to provide additional imaging to improve diagnosis. The use of MRI can help physicians to better analyse abnormalities detected through mammography. The ability to see more clearly with the VIBRANT applications can aid in a quick diagnosis and decisionmaking to prevent unnecessary mastectomies and/or to monitor therapy.

Senographe* Essential Interventional (Stereotaxy)
Our flexible breast care solution, with a mammography system and biopsy system in one.

Ultrasound
Dedicated ultrasound solutions are important for detecting and defining masses in breast tissue in order to perform guided biopsies. GE offers a comprehensive range of 3D ultrasound technologies, including portable solutions for small clinics and mobile units.

*Trademark(s) of General Electric company

Staging

PET/CT
"Fluoro-deoxy-glucose (FDG) PET is assessed as an accurate tool to monitor viability of cancer. There is now evidence that in manay tumors PET is used for diagnosis, staging, detection of relapse, restaging and follow-up" EANM-ESTRO guidelines

MRI with DCE
For women with dense breast tissue or those at high-risk for breast cancer due to family history, MRI is often recommended to provide additional imaging to improve diagnosis. The use of MRI can help physicians to better analyse abnormalities detected through mammography. The ability to see more clearly with the VIBRANT applications can aid in a quick diagnosis and decisionmaking to prevent unnecessary mastectomies and/or to monitor therapy.

Discovery* NM/CT 670
Built on GE’s pioneering legacy in molecular imaging, the Discovery NM/CT 670 leverages our decades of imaging leadership and advanced SPECT and CT technology.The Discovery NM/CT 670 seamlessly integrates the functional images of SPECT with the precise anatomical detail of multislice CT, empowering you to respond with confidence and accuracy in your diagnosis. If a picture’s worth a thousand words, imagine what cutting edge multi slice fusion imagery would be worth.

OncoQuant*
A true cross-modality oncology reading platform, OncoQuant helps you correlate and compare CT, MR, PET /CT, and 3D X-ray data. It automates workflow from your PACS , facilitating easy comparisons over time and efficient follow-up exams.


*Trademark(s) of General Electric company

Risk of recurrence

Mammostrat
Mammostrat is a novel test for estimating the risk for recurrence in hormone-receptor positive, early stage breast cancer that is independent of proliferation and grade.

Monitoring

PET/CT
"Fluoro-deoxy-glucose (FDG) PET is assessed as an accurate tool to monitor viability of cancer. There is now evidence that in manay tumors PET is used for diagnosis, staging, detection of relapse, restaging and follow-up" EANM-ESTRO guidelines

PET VCAR™
Optimized Patient Monitoring in Oncology PET VCAR provides automated and interactive access to valuable quantitative information, and manages multiple lesions and multiple patient exams over time. It has the potential to improve the clinicians' daily reading experience and patient management.

MRI with DWI
For women with dense breast tissue or those at high-risk for breast cancer due to family history, MRI is often recommended to provide additional imaging to improve diagnosis. The use of MRI can help physicians to better analyse abnormalities detected through mammography. The ability to see more clearly with the VIBRANT applications can aid in a quick diagnosis and decisionmaking to prevent unnecessary mastectomies and/or to monitor therapy.

AdvantageSim MD
It prepares geometric and anatomical data relating to a proposed external beam radiation therapy treatment before dosimetry planning. Anatomical volumes can be defined automatically or in 3D using a set of CT images acquired in the proposed treatment position. It also provides the ability to use complementary MR, PET or 4D datasets to increase treatment planning and monitoring accuracy.

Ultrasound
GE offers a comprehensive range of 3D ultrasound technologies, including portable solutions for small clinics and mobile units. CEUS with TIC (w/ or w/o 3D Imaging) may help monitor the patient response to tailored anti-neo angiogenesis treatments for some types of cancers

Circulating tumor cells
Minimally invasive blood test to detect metastasis with HER2 status and potentially identify false negative HER2 results. Enables greater confidence to send additional tissue sections if HER2 status amplified in CTCs

Information management


ArchivingIt simplifies the archiving of “multi-ology” images, huge datasets, diagnostic reports, and other clinical information, delivering a universal clinical data repository. As such it brings to users a way to easily get access to consolidated patient data.

Workflow management
You don't need to chart your path ahead alone. Consider how the GE Performance Solutions can help you address your most pressing capacity strategy, operations transformation, and workflow technology challenges.